2024-03-13 |
2024-03-08 |
S
Sale
|
Garofalo, Elizabeth
Director of Issuer
Non-Executive Director
|
2,092
45.69
95,583
USD
|
2,092
|
45.69
|
95,583
USD
|
|
2024-03-13 |
2024-03-08 |
S
Sale
|
Garofalo, Elizabeth
Director of Issuer
Non-Executive Director
|
1,408
-40.2%
46.16
64,993
USD
|
1,408
-40.2%
|
46.16
|
64,993
USD
|
|
2024-03-13 |
2024-03-08 |
B
Purchase
|
Garofalo, Elizabeth
Director of Issuer
Non-Executive Director
|
3,500
18.56
64,960
USD
|
3,500
|
18.56
|
64,960
USD
|
|
2024-03-11 |
2024-03-08 |
S
Sale
|
GAROFALO ELIZABETH A.
Non-Executive Director
|
2,092
-100.0%
45.69
95,583
USD
|
2,092
-100.0%
|
45.69
|
95,583
USD
|
|
2024-03-12 |
2024-03-07 |
S
Sale
|
Gannon, Steven
Director of Issuer
Non-Executive Director
|
2,000
-50.0%
46.20
92,402
CAD
|
2,000
-50.0%
|
46.20
|
92,402
CAD
|
|
2024-03-12 |
2024-03-07 |
S
Sale
|
Gannon, Steven
Director of Issuer
Non-Executive Director
|
5,000
-55.6%
46.30
231,513
CAD
|
5,000
-55.6%
|
46.30
|
231,513
CAD
|
|
2024-03-12 |
2024-03-07 |
S
Sale
|
Gannon, Steven
Director of Issuer
Non-Executive Director
|
5,000
-35.7%
46.25
231,250
CAD
|
5,000
-35.7%
|
46.25
|
231,250
CAD
|
|
2024-03-12 |
2024-03-07 |
S
Sale
|
Gannon, Steven
Director of Issuer
Non-Executive Director
|
1,000
-6.7%
46.45
46,450
CAD
|
1,000
-6.7%
|
46.45
|
46,450
CAD
|
|
2024-03-11 |
2024-03-07 |
S
Sale
|
Sherrington, Robin Paul
Senior Officer of Issuer
Officer
|
6,118
-42.1%
46.30
283,263
CAD
|
6,118
-42.1%
|
46.30
|
283,263
CAD
|
|
2024-03-11 |
2024-03-07 |
S
Sale
|
Sherrington, Robin Paul
Senior Officer of Issuer
Officer
|
1,019
-6.6%
46.15
47,027
CAD
|
1,019
-6.6%
|
46.15
|
47,027
CAD
|
|
2024-03-11 |
2024-03-07 |
S
Sale
|
Sherrington, Robin Paul
Senior Officer of Issuer
Officer
|
1,289
-7.7%
45.96
59,242
CAD
|
1,289
-7.7%
|
45.96
|
59,242
CAD
|
|
2024-03-11 |
2024-03-07 |
B
Purchase
|
Sherrington, Robin Paul
Senior Officer of Issuer
Officer
|
7,407
+78.7%
9.85
72,959
CAD
|
7,407
+78.7%
|
9.85
|
72,959
CAD
|
|
2024-03-11 |
2024-03-07 |
S
Sale
|
Sherrington, Robin Paul
Senior Officer of Issuer
Officer
|
215
-2.2%
45.96
9,881
CAD
|
215
-2.2%
|
45.96
|
9,881
CAD
|
|
2024-03-11 |
2024-03-07 |
B
Purchase
|
Sherrington, Robin Paul
Senior Officer of Issuer
Officer
|
1,234
+14.7%
9.85
12,155
CAD
|
1,234
+14.7%
|
9.85
|
12,155
CAD
|
|
2024-03-08 |
2024-03-07 |
S
Sale
|
GANNON STEVEN
Non-Executive Director
|
2,000
-50.0%
46.20
92,402
USD
|
2,000
-50.0%
|
46.20
|
92,402
USD
|
|
2024-03-08 |
2024-03-07 |
S
Sale
|
GANNON STEVEN
Non-Executive Director
|
5,000
-55.6%
46.30
231,513
USD
|
5,000
-55.6%
|
46.30
|
231,513
USD
|
|
2024-03-08 |
2024-03-07 |
S
Sale
|
GANNON STEVEN
Non-Executive Director
|
5,000
-35.7%
46.25
231,250
USD
|
5,000
-35.7%
|
46.25
|
231,250
USD
|
|
2024-03-08 |
2024-03-07 |
S
Sale
|
GANNON STEVEN
Non-Executive Director
|
1,000
-6.7%
46.45
46,450
USD
|
1,000
-6.7%
|
46.45
|
46,450
USD
|
|
2024-03-08 |
2024-03-07 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
6,118
-42.1%
46.30
283,263
USD
|
6,118
-42.1%
|
46.30
|
283,263
USD
|
|
2024-03-08 |
2024-03-07 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
1,019
-6.6%
46.15
47,027
USD
|
1,019
-6.6%
|
46.15
|
47,027
USD
|
|
2023-12-18 |
2023-12-14 |
S
Sale
|
Patou, Gary
Director of Issuer
Non-Executive Director
|
7,598
-60.8%
41.05
311,898
USD
|
7,598
-60.8%
|
41.05
|
311,898
USD
|
|
2023-12-18 |
2023-12-13 |
S
Sale
|
Patou, Gary
Director of Issuer
Non-Executive Director
|
3,977
-14.4%
39.84
158,444
USD
|
3,977
-14.4%
|
39.84
|
158,444
USD
|
|
2023-12-18 |
2023-12-13 |
S
Sale
|
Patou, Gary
Director of Issuer
Non-Executive Director
|
2,303
-8.9%
39.10
90,047
USD
|
2,303
-8.9%
|
39.10
|
90,047
USD
|
|
2023-12-18 |
2023-12-13 |
S
Sale
|
Patou, Gary
Director of Issuer
Non-Executive Director
|
5,100
-17.8%
38.94
198,594
USD
|
5,100
-17.8%
|
38.94
|
198,594
USD
|
|
2023-12-15 |
2023-12-13 |
S
Sale
|
PATOU GARY
Non-Executive Director
|
7,598
-60.8%
41.05
311,898
USD
|
7,598
-60.8%
|
41.05
|
311,898
USD
|
|
2023-12-15 |
2023-12-13 |
S
Sale
|
PATOU GARY
Non-Executive Director
|
3,977
-14.4%
39.84
158,444
USD
|
3,977
-14.4%
|
39.84
|
158,444
USD
|
|
2023-12-15 |
2023-12-13 |
S
Sale
|
PATOU GARY
Non-Executive Director
|
2,303
-8.9%
39.10
90,047
USD
|
2,303
-8.9%
|
39.10
|
90,047
USD
|
|
2023-12-15 |
2023-12-13 |
S
Sale
|
PATOU GARY
Non-Executive Director
|
5,100
-17.8%
38.94
198,594
USD
|
5,100
-17.8%
|
38.94
|
198,594
USD
|
|
2023-08-24 |
2023-08-24 |
S
Sale
|
Svoronos Dawn
Non-Executive Director
|
25,000
-50.0%
38.70
967,500
USD
|
25,000
-50.0%
|
38.70
|
967,500
USD
|
|
2023-06-01 |
2023-06-01 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
24,255
-80.2%
38.78
940,609
USD
|
24,255
-80.2%
|
38.78
|
940,609
USD
|
|
2023-06-01 |
2023-06-01 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
7,458
-55.4%
38.97
290,638
USD
|
7,458
-55.4%
|
38.97
|
290,638
USD
|
|
2023-06-01 |
2023-05-31 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
26,856
-81.7%
38.69
1,039,059
USD
|
26,856
-81.7%
|
38.69
|
1,039,059
USD
|
|
2023-06-01 |
2023-05-31 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
23,670
-79.8%
38.81
918,633
USD
|
23,670
-79.8%
|
38.81
|
918,633
USD
|
|
2023-06-01 |
2023-05-31 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
12,000
-66.7%
38.53
462,360
USD
|
12,000
-66.7%
|
38.53
|
462,360
USD
|
|
2023-06-01 |
2023-05-30 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
19,000
-51.4%
39.90
758,100
USD
|
19,000
-51.4%
|
39.90
|
758,100
USD
|
|
2023-06-01 |
2023-05-30 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
18,006
-32.7%
38.63
695,572
USD
|
18,006
-32.7%
|
38.63
|
695,572
USD
|
|
2023-05-26 |
2023-05-24 |
S
Sale
|
MORTIMER IAN
PRESIDENT & CEO
Executive Director
|
1,407
-4.3%
41.49
58,376
USD
|
1,407
-4.3%
|
41.49
|
58,376
USD
|
|
2023-05-26 |
2023-05-24 |
S
Sale
|
MORTIMER IAN
PRESIDENT & CEO
Executive Director
|
13,179
-32.2%
41.37
545,215
USD
|
13,179
-32.2%
|
41.37
|
545,215
USD
|
|
2023-05-26 |
2023-05-24 |
S
Sale
|
MORTIMER IAN
PRESIDENT & CEO
Executive Director
|
17,069
-41.3%
41.44
707,339
USD
|
17,069
-41.3%
|
41.44
|
707,339
USD
|
|
2023-03-24 |
2023-03-24 |
S
Sale
|
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Officer
|
700
-100.0%
35.01
24,507
USD
|
700
-100.0%
|
35.01
|
24,507
USD
|
|
2023-03-09 |
2023-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
8,242
-13.0%
36.94
304,459
USD
|
8,242
-13.0%
|
36.94
|
304,459
USD
|
|
2023-03-09 |
2023-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
10,990
-24.4%
37.01
406,740
USD
|
10,990
-24.4%
|
37.01
|
406,740
USD
|
|
2022-11-28 |
2022-11-25 |
S
Sale
|
PATOU GARY
Non-Executive Director
|
1,937
-7.6%
34.79
67,390
USD
|
1,937
-7.6%
|
34.79
|
67,390
USD
|
|
2022-11-28 |
2022-11-23 |
S
Sale
|
PATOU GARY
Non-Executive Director
|
2,057
-8.0%
34.33
70,610
USD
|
2,057
-8.0%
|
34.33
|
70,610
USD
|
|
2022-09-07 |
2022-09-02 |
S
Sale
|
AULIN SHERRY
Chief Financial Officer
Officer
|
15,355
-100.0%
39.57
607,597
USD
|
15,355
-100.0%
|
39.57
|
607,597
USD
|
|
2022-09-02 |
2022-09-01 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
8,776
-34.3%
38.80
340,509
USD
|
8,776
-34.3%
|
38.80
|
340,509
USD
|
|
2022-09-02 |
2022-09-01 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
35,103
-57.9%
38.03
1,334,967
USD
|
35,103
-57.9%
|
38.03
|
1,334,967
USD
|
|
2022-09-02 |
2022-08-31 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
21,352
-56.0%
38.57
823,547
USD
|
21,352
-56.0%
|
38.57
|
823,547
USD
|
|
2022-08-16 |
2022-08-16 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
20,000
-76.9%
38.87
777,400
USD
|
20,000
-76.9%
|
38.87
|
777,400
USD
|
|
2022-08-16 |
2022-08-16 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
32,058
-55.2%
38.29
1,227,501
USD
|
32,058
-55.2%
|
38.29
|
1,227,501
USD
|
|
2022-08-16 |
2022-08-15 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
33,942
-36.9%
37.76
1,281,650
USD
|
33,942
-36.9%
|
37.76
|
1,281,650
USD
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
1,000
-1.1%
39.15
39,150
USD
|
1,000
-1.1%
|
39.15
|
39,150
USD
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
47,000
-33.6%
38.60
1,814,200
USD
|
47,000
-33.6%
|
38.60
|
1,814,200
USD
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
43,135
-23.6%
37.91
1,635,248
USD
|
43,135
-23.6%
|
37.91
|
1,635,248
USD
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
EMPFIELD JAMES R.
EVP, Drug Discovery
Officer
|
21,875
-68.6%
38.68
846,125
USD
|
21,875
-68.6%
|
38.68
|
846,125
USD
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
EMPFIELD JAMES R.
EVP, Drug Discovery
Officer
|
35,868
-52.9%
38.08
1,365,853
USD
|
35,868
-52.9%
|
38.08
|
1,365,853
USD
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.3%
30.50
76,250
USD
|
2,500
-1.3%
|
30.50
|
76,250
USD
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.3%
30.55
76,375
USD
|
2,500
-1.3%
|
30.55
|
76,375
USD
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.3%
30.20
75,500
USD
|
2,500
-1.3%
|
30.20
|
75,500
USD
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.3%
30.10
75,250
USD
|
2,500
-1.3%
|
30.10
|
75,250
USD
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.3%
3.80
9,500
USD
|
2,500
-1.3%
|
3.80
|
9,500
USD
|
|
2022-03-08 |
2022-03-08 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,051
-1.0%
30.60
62,761
USD
|
2,051
-1.0%
|
30.60
|
62,761
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
EMPFIELD JAMES R.
EVP, Drug Discovery
Officer
|
31,048
-75.6%
30.54
948,206
USD
|
31,048
-75.6%
|
30.54
|
948,206
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
EMPFIELD JAMES R.
EVP, Drug Discovery
Officer
|
1,805
-4.2%
30.62
55,269
USD
|
1,805
-4.2%
|
30.62
|
55,269
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.2%
30.55
76,375
USD
|
2,500
-1.2%
|
30.55
|
76,375
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
7,500
-3.6%
30.50
228,750
USD
|
7,500
-3.6%
|
30.50
|
228,750
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
2,500
-1.2%
30.52
76,300
USD
|
2,500
-1.2%
|
30.52
|
76,300
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
4,516
-2.1%
30.44
137,467
USD
|
4,516
-2.1%
|
30.44
|
137,467
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
4,516
-2.1%
30.45
137,512
USD
|
4,516
-2.1%
|
30.45
|
137,512
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
4,517
-2.0%
30.49
137,723
USD
|
4,517
-2.0%
|
30.49
|
137,723
USD
|
|
2022-03-08 |
2022-03-07 |
S
Sale
|
PIMSTONE SIMON N.
Non-Executive Director
|
5,037
-2.2%
30.60
154,132
USD
|
5,037
-2.2%
|
30.60
|
154,132
USD
|
|
2022-03-08 |
2022-03-04 |
S
Sale
|
EMPFIELD JAMES R.
EVP, Drug Discovery
Officer
|
18,315
-64.7%
30.79
563,919
USD
|
18,315
-64.7%
|
30.79
|
563,919
USD
|
|
2022-03-08 |
2022-03-04 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
5,000
-22.5%
30.23
151,150
USD
|
5,000
-22.5%
|
30.23
|
151,150
USD
|
|
2022-03-08 |
2022-03-04 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
5,000
-18.4%
31.05
155,250
USD
|
5,000
-18.4%
|
31.05
|
155,250
USD
|
|
2022-03-08 |
2022-03-04 |
S
Sale
|
ROBIN SHERRINGTON
EVP, Strategy & Innovation
Officer
|
5,000
-15.5%
30.15
150,750
USD
|
5,000
-15.5%
|
30.15
|
150,750
USD
|
|